NewsBenzingaArcturus Therapeutics表示ARCT-810通常安全且耐受良好，在进行中的2期研究中展现出对关键尿素循环生物标志物有鼓舞人心的活性 Arcturus Therapeutics表示ARCT-810通常安全且耐受良好，在进行中的2期研究中展现出对关键尿素循环生物标志物有鼓舞人心的活性 Benzinga 2026.09.23 20:08 (GMT+0) Open on Benzinga Other news If You Invested $100 In Watts Water Technologies Stock 5 Years Ago, You Would Have This Much Today Minerals Technologies Unveils Innovations And Strategic Growth Targets At 2026 Investor Day; Reiterates Long-Term Targets And Highlights Value Creation Opportunities; Presents Capability To Produce High-Purity Calcium Metal To Support Domestic Heavy... $1000 Invested In MKS 15 Years Ago Would Be Worth This Much Today Dozens Of U.S. Oil Refining And Business Groups Urge Trump To Reject Any Effort To Impose Ban On Diesel Exports Viking Therapeutics Stock Drops In After Hours on Proposed Public Offerings TransUnion CFO Todd M. Cello Announces Resignation, Effective December 31, 2026; Co Reaffirms 2026 Financial Outlook
Minerals Technologies Unveils Innovations And Strategic Growth Targets At 2026 Investor Day; Reiterates Long-Term Targets And Highlights Value Creation Opportunities; Presents Capability To Produce High-Purity Calcium Metal To Support Domestic Heavy...
Dozens Of U.S. Oil Refining And Business Groups Urge Trump To Reject Any Effort To Impose Ban On Diesel Exports
TransUnion CFO Todd M. Cello Announces Resignation, Effective December 31, 2026; Co Reaffirms 2026 Financial Outlook
